Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Dec 22;137(3):817–828. doi: 10.1007/s10549-012-2370-4

Table 3.

Continuously measured variables and differences by age related to treatment decision process and considerations, psychosocial factors, provider communication and involvement among women with non-metastatic breast cancer interviewed in the BQUAL Study, 2006-2010 (n=1145)

All (N=1,145) Age <50 (N=268, 23%) Age 50-64 (N=543, 47%) Age ≥ 65 (N=334, 29%)
Treatment Considerations Mean (SD) Potential Range Actual Range Mean (SD) Mean (SD) Mean (SD) pvalue
Decision-making considerations for Chemotherapy:
    Physical 0.7 (0.8) 0-2 0-2 0.7(0.8) 0.7(0.8) 0.8(0.8) 0.06
    Negative balance 1.6 (1.4) 0-5 0-5 1.2(1.3) 1.5(1.4) 2.0(1.3) <0.0001
    Positive balance 2.4 (1.0) 0-3 0-3 2.7(0.7) 2.4(1.0) 2.0(1.1) <0.0001
    Concrete considerations 1.1 (1.2) 0-4 0-4 1.2(1.2) 1.0(1.2) 1.1(1.2) 0.39
    Family and friends 0.4 (0.5) 0-1 0-1 0.4(0.5) 0.4(0.5) 0.3(0.5) 0.12
Decision-making considerations for Hormonal Therapy:
    Physical 0.6 (0.5) 0-1 0-1 0.6(0.5) 0.6(0.5) 0.6(0.5) 1.0
    Negative balance 1.1 (1.3) 0-5 0-5 1.0(1.3) 1.1(1.3) 1.3(1.4) 0.01
    Positive balance 2.7 (0.7) 0-3 0-3 2.8(0.5) 2.7(0.7) 2.5(0.8) <0.0001
    Concrete Considerations 0.8 (1.0) 0-3 0-3 0.8(1.1) 0.7(1.0) 0.8(1.0) 0.58
    Family and friends 0.3 (0.5) 0-1 0-1 0.3(0.5) 0.3(0.5) 0.3(0.5) 0.99
Psychosocial Factors
Attitude towards Chemotherapy 2.9 (0.6) 1-4 1-4 3.0(0.5) 2.9(0.6) 2.7(0.6) <0.0001
You are less likely to have the cancer come back if you have chemotherapy 3.0 (1.0) 1-4 1-4 3.2(1.0) 3.0(1.0) 2.7(1.1) <0.0001
Chemotherapy does not help you live longer 1.9 (1.1) 1-4 1-4 1.7(1.0) 1.9(1.0) 2.0(1.1) 0.001
Chemotherapy could cause long-term health problem 2.8 (1.0) 1-4 1-4 2.7(1.0) 2.8(0.9) 2.8(1.0) 0.06
Chemotherapy is not as effective in older women as it is in younger women 1.7 (1.0) 1-4 1-4 1.7(0.9) 1.7(1.0) 1.9(1.0) 0.01
Chemotherapy kills all remaining cancer cells 2.7 (1.1) 1-4 1-4 2.9(1.0) 2.7(1.1) 2.5(1.0) 0.0002
Chemotherapy is experimental 1.9 (1.0) 1-4 1-4 1.8(1.0) 1.9(1.0) 2.0(1.1) 0.35
The side effects of chemotherapy are worse than the disease 2.2 (1.2) 1-4 1-4 2.1(1.2) 2.1(1.1) 2.4(1.1) 0.0007
Attitude towards Hormonal Therapy 2.9 (0.6) 1-4 1-4 2.9(0.6) 3.0(0.5) 2.9(0.6) 0.054
You are less likely to have the cancer come back if you have Hormonal Therapy 3.1 (0.9) 1-4 1-4 3.1(0.9) 3.2(0.9) 3.1(1.0) 0.09
Hormonal Therapy does not help you live longer 1.9 (1.0) 1-4 1-4 1.8(1.0) 1.7(1.0) 2.1(1.1) <0.0001
Hormonal Therapy could cause long-term health problem 2.4 (0.9) 1-4 1-4 2.5(0.9) 2.5(0.9) 2.3(1.0) 0.02
Hormonal Therapy is not as effective in older women as it is in younger women 1.7 (0.9) 1-4 1-4 1.9(1.0) 1.5(0.8) 1.8(1.0) <0.0001
Hormonal Therapy kills all remaining cancer cells 1.9 (1.0) 1-4 1-4 1.8(1.0) 1.9(1.1) 2.0(1.0) 0.47
Hormonal Therapy is experimental 2.1 (1.0) 1-4 1-4 2.0(1.0) 2.1(1.0) 2.1(1.0) 0.45
The side effects of Hormonal Therapy are worse than the disease 1.6 (0.9) 1-4 1-4 1.6(0.9) 1.5(0.9) 1.6(0.9) 0.41
Treatment Expectations for Chemotherapy
    Fatigue 6.7 (2.2) 0-10 0-10 6.4(2.2) 6.8(2.2) 6.6(2.2) 0.02
    Nausea 5.7 (2.8) 0-10 0-10 5.5(2.8) 5.8(2.8) 8.8(2.9) 0.35
    Hearing loss 1.3 (2.2) 0-10 0-10 1.1(1.9) 1.1(2.1) 1.7(2.4) 0.001
    Pain 4.3 (2.8) 0-10 0-10 4.1(2.6) 4.3(2.8) 4.4(2.9) 0.45
    Side effects 6.4 (2.5) 0-10 0-10 6.5(2.5) 6.5(2.5) 6.3(2.6) 0.71
Fatalism 19.6 (3.2) 8-32 9-31 18.9(3.4) 19.6(3.2) 20.3(3.0) <0.0001
Social Support 4.3 (0.7) 1-5 1.4-5 4.3(0.7) 4.3(0.7) 4.2(0.6) 0.76
    Emotional/Information Support 34.1 (4.9) 8-40 8-40 34.4(4.7) 34.3(4.9) 33.5(4.9) 0.03
    Tangible Support 17.2 (3.2) 4-20 4-20 17.2 (3.2) 17.3(3.3) 17.1(3.1) 0.70
    Affectionate Support 13.7 (2.2) 3-15 3-15 13.7(2.2) 13.7(2.2) 13.6(2.1) 0.84
    Positive Social Interaction 12.9 (2.3) 3-15 3-15 12.8(2.4) 12.9(2.3) 12.9(2.1) 0.86
Structural Social Support 14.0 (13.9) Write-in 0 – 200 13.7(11.1) 14.9(15.9) 13.0(10.0) 0.11
Provider-related Factors and Communication
Patient Involvement in Treatment Decision 12.5 (2.5) 3-18 4-18 12.4(2.4) 12.6(2.6) 12.4(2.4) 0.28
The doctor gave me the responsibility for deciding how to deal with my breast cancer 4.3 (1.1) 1-6 1-6 4.2(1.1) 4.3(1.2) 4.3(1.0) 0.56
The doctor asked me to choose a treatment for my breast cancer 3.6 (1.2) 1-6 1-6 3.5(1.2) 3.7(1.3) 3.7(1.1) 0.19
The doctor gave me all the information needed about my breast cancer 4.6 (1.0) 1-6 1-6 4.6(1.0) 4.7(1.0) 4.5(1.0) 0.08
Provider Communication for Chemotherapy 18.0 (3.6) 4-24 4 - 24 18.1(3.5) 18.3(3.5) 17.3(3.6) 0.0004
The doctor gave you enough information to make your own decision about chemotherapy treatment 4.8 (1.0) 1-6 1-6 4.8(1.0) 4.8(1.0) 4.6(1.0) 0.08
The doctor fully explained the benefits of chemotherapy. 4.6 (1.1) 1-6 1-6 4.7(1.0) 4.7(1.0) 4.4(1.1) <0.0001
The doctor fully explained the risks of chemotherapy 4.4 (1.1) 1-6 1-6 4.5(1.1) 4.5(1.1) 4.2(1.2) 0.0006
The doctor did not ask your opinion about taking chemotherapy. 2.8 (1.2) 1-6 1-6 2.8(1.2) 2.7(1.2) 2.8(1.2) 0.15
Provider Communication for Hormonal Therapy 15.5 (2.7) 4-24 4-24 15.3(2.9) 15.8(2.5) 15.3(2.7) 0.04
The doctor gave you enough information to make your own decision about Hormonal Therapy 4.4 (1.1) 1-6 1-6 4.3(1.2) 4.4(1.1) 4.3(1.1) 0.36
The doctor fully explained the benefits of Hormonal Therapy 4.4 (1.0) 1-6 1-6 4.3(1.0) 4.5(1.0) 4.3(1.0) 0.02
The doctor fully explained the risks of Hormonal Therapy 4.0 (1.1) 1-6 1-6 3.9(1.1) 4.1(1.1) 3.9(1.1) 0.05
The doctor did not ask your opinion about taking Hormonal Therapy 2.9 (1.2) 1-6 1-6 2.9(1.2) 2.8(1.3) 2.9(1.1) 0.77
Medical Mistrust 20.6 (7.1) 13-65 3-49 21.0(7.2) 20.6(7.3) 20.3(6.6) 0.45
    Suspicion 9.2 (3.6) 6-30 2-24 9.3(3.5) 9.2(3.7) 9.2(3.5) 0.94
    Discrimination 6.1 (2.7) 3-15 2-15 6.3(2.7) 6.2(2.9) 5.9(2.4) 0.21
    Lack of support 5.3 (2.1) 3-15 2-15 5.5(2.1) 5.3(2.1) 5.2(1.9) 0.26